guselkumab,golimumab
janssen
['vega', 'golimumab', 'ibd', ' gus ', 'guselkumab', 'ease,(-please),(-disease),(-incrrease),(-decrease)']
 induction combo therapy with guselkumab/golimumab followed by gus monotherapy maintenance (vega). #uegweek22 #ibd -bio-naive pts
-no increased discontinuation in combo-group
-superiority of combo maintained by wk38
-no safety signals 
Professor of Medicine, Gastroenterologist, specializing in the care of patients with IBD.
National representative of Germany @ https://t.co/Qr0PthTmU8 ex @Y_ECCO_IBD chair